Skip to main content

Table 1 Schedule and doses of dacetuzumab in Cycle 1 and additional cycles

From: A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

 

Dacetuzumab dose, mg/kg

Week 1

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

Day 1

Day 4

Day 8

Day 15

Day 22

Day 29

Day 36

Cycle 1

1

2

4

8

8

8

Restage

Cycles 2-12

8

8

8

8

Restage